Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 5, 2008, Pages 415-422

  Smith, L J ^a,c   KuKanich, B ^b   Hogan, B K ^a   Brown, C ^a   Heath, T D ^a   Krugner Higby, L A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; HYDROMORPHONE; LIPOSOME;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED RELEASE FORMULATION; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG HALF LIFE; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; DOGS; HALF-LIFE; HYDROMORPHONE; INJECTIONS, SUBCUTANEOUS; LIPOSOMES; MALE; METABOLIC CLEARANCE RATE;

CANIS FAMILIARIS;

EID: 53149127315     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00974.x     Document Type: Article

References (16)

1. Clark, M.D., Krugner-Higby, L., Smith, L.J., Heath, T.D., Clark, K.L. Olson, D. (2004) Evaluation of liposome encapsulated (LE) oxymorphone hydrochloride in mice after splenectomy mice. Comparative Medicine, 54, 518 523.
2. Coda, B.A., Tanaka, A., Jacobson, R.C., Donaldson, G. Chapman, C.R. (1997) Hydromorphone analgesia after intravenous bolus administration. Pain, 71, 41 48.
3. Dunbar, P.J., Chapman, C.R., Buckley, F.P. Gavrin, J.R. (1996) Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain, 68, 265 270.
4. Hennies, H.H., Friderichs, E. Schneider, J. (1988) Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung, 38, 877 880.
5. Ishida, T., Horashima, H. Kiwada, H. (2002) Liposome Clearance. Bioscience Reports, 22, 197 224.
6. Krugner-Higby, L., Smith, L., Clark, M., Heath, T.D., Dahly, E., Schiffman, B., Hubbard-VanStelle, S., Ney, D. Wendland, A. (2003) Liposome-encapsulated oxymorphone hydrochloride provides prolonged relief of post-surgical visceral pain in rats. Comparative Medicine, 53, 270 279.
7. Kukanich, B., Hogan, B.K., Krugner-Higby, L.A. Smith, L.J. (2008) Pharmacokinetics of hydromorphone hydrochloride in healthy dogs. Veterinary Anaesthesia Analgesia, 35, 256 264.
8. Lawlor, P., Turner, K., Hanson, J. Bruera, E. (1997) Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain, 72, 79 85.
9. Mahler, D.L. Forrest, W.H. Jr (1975) Relative analgesic potencies of morphine and hydromorphone in postoperative pain. Anesthesiology, 42, 602 607.
10. Schlitt, S.C., Schroeter, L.M., Wilson, J.E. Olsen, G.D. (1978) Methadone-induced respiratory depression in the dog: comparison of steady-state and rebreathing techniques and correlation with serum drug concentration. Journal of Pharmacoogy and Experimental Therapeutics, 207, 109 122.
11. Senior, J. Gregoriadis, G. (1982) Stability of small unilamellar liposomes in serum and clearance from circulation: the effect of the phospholipid and cholesterol components. Life Sciences, 30, 2123 2136.
12. Smith, L.J., Krugner-Higby, L., Heath, T. Clark, M. (2003) A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain. Comparative Medicine, 53, 280 287.
13. Smith, L.J., Krugner-Higby, L., Trepanier, L.A., Flaska, D.E., Joers, V. Heath, T.D. (2004) Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs. Journal of Veterinary Pharmacology and Therapeutics, 27, 1 4.
14. Smith, L.J., Valenzuela, J.R., Krugner-Higby, L.A., Brown, C. Heath, T.D. (2006) A single dose of liposome-encapsulated hydromorphone provides extended relief of hyperalgesia in a rodent model of neuropathic pain. Comparative Medicine, 56, 487 492.
15. Toutain, P.L. Bousquet-Melou, A. (2004) Plasma terminal half-life. Journal of Veterinary Pharmacology and Therapeutics, 27, 427 439.
16. Wasan, K. Lopez-Berestein, G. (1996) Characteristics of lipid-based formulations that influence the biological behavior in the plasma of patients. Clinical Infectious Diseases, 23, 1126 1138.